9th Annual Biomarkers Congress
High-Content Analysis Europe: High content Cellular Assays for compound screening and Pahtway Analysis (Sep 24-26)
Prague Marriott Hotel
V Celnici 8, 1100 00 Praha 1, Czech Republic
Praha, mm
Cambridge Healthtech Institute's Second Annual High-Content Analysis Europe: High content Cellular Assays for compound screening and Pahtway Analysis

Schedule of Presentations:

Monday, September 24, 2007
09:30:00 Pre-Conference Workshop: Workshop Registration (09:30-10:00)
10:00:00 Pre-Conference Workshop: GE Healthcare IN Cell Analyzer Technology Workshop (10:00-12:00) Robert Graves, Jacob Tesdorpf, Liz Roquemore
16:30:00 Early Conference Registration (16:30-17:30)
Tuesday, September 25, 2007
07:30:00 Conference Registration (07:30-08:30)
08:30:00 Welcoming Remarks from Conference Director (08:30-08:40) Julia Boguslavsky
08:40:00 HCA for Compound Screening: Case Study - Monitoring of Chemokine Receptor Activation Using High-Content Screening (08:40-09:10) Case Study Ralf Heilker
08:40:00 HCA for Compound Screening (08:40-1130) Ralf Heilker, Koen Van Acker, Marcel B. Bally
09:10:00 HCA for Compound Screening: Identification of HIV-1 Entry Fusion Inhibitors Using a Homogeneous Competitive Cell-Based Binding Assay on a High-Content Screening Platform(09:10-09:40) Koen Van Acker
09:40:00 HCA for Compound Screening: HCS Assays for Assessing Anticancer Drug Combination Effects (09:40-10:10) Marcel B. Bally
10:10:00 HCA for Compound Screening: To be Announced (10:10-10:40)
10:40:00 HCA for Compound Screening: Coffee Break with Poster and Exhibit Viewing (10:40-11:30)
11:30:00 New Technology Showcase (11:30-14:00) Michael A Mancini, Mark Collins, Kris Ver Donck
11:30:00 New Technology Showcase: Get RAD-icle - Overcoming the Assay Optimization Bottleneck in HCS (11:30-11:45) Mark Collins
11:45:00 New Technology Showcase: Multiplex Analyses of Nuclear Receptor Function by High Throughput Imaging (11:45-12:00) Michael A Mancini
12:00:00 New Technology Showcase: New Developments in HCS Screening Related to Brightfield, Automated User Defined Focus Points and Unique Data Mining Tools for Increased Data Quality and Assessment (12:00-12:15) Kris Ver Donck
12:15:00 New Technology Showcase: Technology Short Talk (12:15-12:30)
12:30:00 New Technology Showcase: Lunch on Your Own (12:30-14:00)
14:00:00 HCA for Toxicity and Efficacy Assessment (14:00-16:00) Anthony Davies, Peter O'Brien
14:00:00 HCA for Toxicity and Efficacy Assessment: Use of HCA for Translational Safety Biomarkers (14:00-14:30) Peter O'Brien
14:30:00 HCA for Toxicity and Efficacy Assessment: Development of Cell-Based Assays for Study of Cardiac Disease and Drug Efficacy and Toxicity Using Primary Cardiomyocytes and Cardiac-Derived Cell Lines in a High-Content Format (14:30-15:00) Anthony Davies
15:00:00 HCA for Toxicity and Efficacy Assessment: Refreshment Break with Poster and Exhibit Viewing (15:00-16:00)
16:00:00 HCA for Mechanism-of-Action Studies (16:00-18:00) Claire Scott, Philip Denner
16:00:00 HCA for Mechanism-of-Action Studies: Use of the BD Pathway in CNS Drug Discovery to Determine Mechanisms of Compound Action in Primary Neuronal Cultures (16:00-16:30) Claire Scott
16:30:00 HCA for Mechanism-of-Action Studies: Development of Automated Image Analysis Routines for Functional HCA (16:30-17:00) Philip Denner
17:00:00 HCA for Mechanism-of-Action Studies: Cocktail Reception with Exhibit and Poster Viewing (17:00-18:00)
Wednesday, September 26, 2007
07:30:00 Breakfast Technology Workshop Quantitative Imaging Approaches in Drug Discovery (07:30-08:15) Werner Stürmer
08:30:00 ThinkTank Roundtable Discussions (08:30-09:30)
09:30:00 Coffee Break with Exhibit and Poster Viewing (09:30-10:15)
10:15:00 HCA for RNAi Screening: Large-Scale siRNA Screening for Functional Genomics in Endocytosis (10:15-10:45) Martin Stöter
10:15:00 HCA for RNAi Screening (10:15-12:15) Michael Hannus, Anja van Brabant-Smith, Remko de Pril, Martin Stöter
10:45:00 HCA for RNAi Screening: Identification of Novel Anti-Malarial Targets and Lead Compounds Using High-Content Microscopy Assay for RNAi and Drug Screens (10:45-11:15) Michael Hannus
11:15:00 HCA for RNAi Screening: A High-Content Assay Reveals the Potential Role of microRNA Clusters in Cell Growth and Transformation (11:15-11:45) Anja van Brabant-Smith
11:45:00 HCA for RNAi Screening: Drugable Genome-Wide RNAi Screen in Huntington Disease Applying High-Content Analysis (11:45-12:15) Remko de Pril
12:15:00 Close of Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.